Since ischemia participates in Alzheimer’s disease (AD) pathogenesis through cerebral insults and accumulation of β-amyloid and phosphorylated tau protein, the anti-ischemic and neuroprotective properties of protein S may actively decrease the risk of AD [78,79]. Here, MAPT is linked to Alzheimer disease.